Polpharma Biologics is splitting its operations into two independent companies, each with a clear focus and mission.
We will operate our biosimilars business out of Switzerland, under the original brand – Polpharma Biologics. We remain dedicated to developing and commercializing our pipeline of high-quality biologic medicines. We chose Switzerland, a strong biotech hub, for its proximity to our business partners and for its top industry talent.
Our CDMO business has launched today under a new brand: Rezon Bio. We are building on our expertise and track record, to deliver cost-efficient solutions for biotech partners worldwide, from our state-of-the-art facilities in Poland, fully compliant with the highest international regulatory standards.
With sharpened focus and independence, both Polpharma Biologics and Rezon Bio are individually better positioned to compete globally and create value for partners and patients. This step is a continuation of our growth journey, rooted in the same strong foundations.
To stay up to date with the activities of both companies, follow their profiles on LinkedIn and visit the new Rezon Bio website:
LinkedIn Polpharma Biologics
LinkedIn Rezon Bio
Rezon Bio Website
